The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lamictal 25mg dispersible/chewable tablets

25 milligram(s) Dispersible tablet

Imbat LimitedPPA1151/115/001

Main Information

Trade NameLamictal 25mg dispersible/chewable tablets
Active SubstancesLamotrigine
Strength25 milligram(s)
Dosage FormDispersible tablet
Licence HolderImbat Limited
Licence NumberPPA1151/115/001

Group Information

ATC CodeN03AX Other antiepileptics
N03AX09 lamotrigine


Licence Issued21/08/2009
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back